Literature DB >> 20116345

Acquisition of equal or better planning results with interstitial brachytherapy when compared with intensity-modulated radiotherapy in tongue cancers.

N V N Madhusudhana Sresty1, Thogata Ramanjappa, Alluri Krishnam Raju, K R Muralidhar, Gambhir Sudarshan.   

Abstract

PURPOSE: Intensity-modulated radiotherapy (IMRT) technique in external beam radiotherapy and interstitial implant brachytherapy (ISBT) play important role in the treatment of head and neck cancers. Both are proved to be highly conformal techniques of radiotherapy. In this study, we investigated whether ISBT can give treatment planning results similar to those of IMRT. METHODS AND MATERIALS: Fifteen patients with tongue cancer treated with interstitial high-dose-rate brachytherapy were replanned. They were evaluated with the IMRT planning system. Contouring of target volume, including all critical structures was done on the IMRT treatment planning system to closely match implant brachytherapy planning system. Treatment plans were generated after specifying the goals in the prescription. Conformity index and dose to critical organ were calculated and compared between IMRT and ISBT. Planning time was also recorded for both the techniques in all the cases.
RESULTS: Very good dose conformity was observed in ISBT, which was almost the same as that in IMRT. Dose to the critical structure was lower in ISBT in all the cases. Planner time was also less in ISBT for more number of cases.
CONCLUSIONS: Results show that ISBT treatment modality produces equal or superior planning results when compared with IMRT with our optimization techniques. These results encourage us to continue ISBT practice. (c) 2010 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20116345     DOI: 10.1016/j.brachy.2009.05.006

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  5 in total

1.  Role of high dose rate interstitial brachytherapy in early and locally advanced squamous cell carcinoma of buccal mucosa.

Authors:  Parthasarathy Vedasoundaram; Aravind Kumar Prasanna; Reddy Ks; Gangothri Selvarajan; Mourougan Sinnatamby; Seenisamy Ramapandian; Saravanan Kandasamy
Journal:  Springerplus       Date:  2014-10-09

2.  Clinical outcome of high-dose-rate interstitial brachytherapy in patients with oral cavity cancer.

Authors:  Sung Uk Lee; Kwan Ho Cho; Sung Ho Moon; Sung Weon Choi; Joo Yong Park; Tak Yun; Sang Hyun Lee; Young Kyung Lim; Chi Young Jeong
Journal:  Radiat Oncol J       Date:  2014-12-30

3.  Image guided high-dose-rate brachytherapy versus volumetric modulated arc therapy for head and neck cancer: A comparative analysis of dosimetry for target volume and organs at risk.

Authors:  Hironori Akiyama; Csilla Pesznyák; Dalma Béla; Örs Ferenczi; Tibor Major; Csaba Polgár; Zoltán Takácsi-Nagy
Journal:  Radiol Oncol       Date:  2018-11-12       Impact factor: 2.991

4.  Adjuvant interstitial three-dimensional pulse-dose-rate-brachytherapy for lip squamous cell carcinoma after surgical resection.

Authors:  Artur Jan Chyrek; Grzegorz Mikołaj Biele Bielęda; Wojciech Maria Burchardt; Adam Chicheł; Piotr Andrzej Wojcieszek
Journal:  J Contemp Brachytherapy       Date:  2019-04-29

Review 5.  High dose rate brachytherapy for oral cancer.

Authors:  Hideya Yamazaki; Ken Yoshida; Yasuo Yoshioka; Kimishige Shimizutani; Souhei Furukawa; Masahiko Koizumi; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2012-11-23       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.